STEM CELL THERAPEUTICS CORP — Form D

STEM CELL THERAPEUTICS CORP of Toronto, A6, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-23. The offering totals $60.7M, of which $30.3M was reported sold. Industry: Biotechnology.

Offering

Filed: 2013-12-23
Form: D
Accession: 0001140361-13-047323
Industry: Biotechnology
Exemptions: 06b
Total offering: $60.7M
Amount sold: $30.3M
Remaining: $30.4M
Investors: 22
Date of first sale: 2013-12-13
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-208615

Issuer

Name: STEM CELL THERAPEUTICS CORP
CIK: 0001392333
Entity type: Corporation
Jurisdiction: ONTARIO, CANADA
Address: 96 Skyway Avenue, Toronto, A6, M9W 4Y9
Phone: 416-457-4670

Officers, directors & promoters (11)

Name	Role	Location
David Geoffrey Peter Allan	Director	Toronto, A6
James Michael DeMesa	Director	Toronto, A6
Henry G Friesen	Director	Toronto, A6
Michael G Moore	Director	Toronto, A6
Ronald Dean Peterson	Director	Toronto, A6
Niclas Stiernholm	Director	Mississauga, A6
Calvin Ralph Stiller	Director	Toronto, A6
James Todd Parsons	Executive Officer	Toronto, A6
Penka Petrova	Executive Officer	Mississauga, A6
Niclas Stiernholm	Executive Officer	Mississauga, A6
Robert Uger	Executive Officer	Mississauga, A6

More